Efficacy and safety of nebulized drugs in the treatment of non-severe mycoplasma pneumoniae pneumonia in children - a network meta-analysis
Abstract
OBJECTIVE: To systematically evaluate the efficacy and safety of commonly used nebulized drugs as adjuvant treatment for non-severe mycoplasma pneumoniae pneumonia (MPP) in children, providing an evidence-based reference for clinical medication.
METHODS: A computerized search of major Chinese and English literature databases was conducted to collect randomized controlled trials (RCTs) that utilized nebulized drugs in conjunction with azithromycin (AZM) or AZM alone in children with MPP. Following literature screening, the quality of the included studies was evaluated using the risk of bias assessment tool as recommended by the Cochrane Handbook. Outcome data for each measurement were extracted, and a network meta-analysis was conducted using Stata 17.0.
RESULTS: A total of 79 RCTs involving 7,712 patients and 9 interventions were included. The network meta-analysis indicated that all nebulized drugs combined with AZM markedly improved clinical efficacy compared to AZM alone. Among these, the combination of nebulized budesonide plus terbutaline demonstrated superior efficacy and safety as adjunctive therapy for non-severe MPP. Furthermore, Ambroxol combined with AZM was particularly effective in shortening the duration of clinical symptoms such as fever and lung rales. The combinations of terbutaline or budesonide with AZM significantly improved pulmonary function.
CONCLUSION: Nebulized drug adjuvants to AZM therapy enhance treatment efficacy in children with non-severe MPP…
How strong is the evidence?
Evidence Hub reads this as a meta-analysis, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid. Reported size: 7,712 participants or records.
Read the paper
Related studies
- Severe clinical outcomes of COVID-19 associated with proton pump inhibitors: a nationwide cohort study with propensity score matching
- Penicillins for Treatment of Pneumococcal Pneumonia: Does In Vitro Resistance Really Matter?
- Thiophenes—Naturally Occurring Plant Metabolites: Biological Activities and In Silico Evaluation of Their Potential as Cathepsin D Inhibitors
- Inhalable Mannosylated Rifampicin–Curcumin Co-Loaded Nanomicelles with Enhanced In Vitro Antimicrobial Efficacy for an Optimized Pulmonary Tuberculosis Therapy
- Development and validation of microbial bioassay for quantification of Levofloxacin in pharmaceutical preparations
- Association between cord blood 25-hydroxyvitamin D concentrations and respiratory tract infections in the first 6 months of age in a Korean population: a birth cohort study (COCOA)
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.